Event to include forums on venture funding, pharmaceutical collaborations
MADISON, Wis., Nov. 29, 2006—The Wisconsin Biotechnology & Medical Device Association, the voice of the state’s growing bioscience industry, today announced plans for its annual meeting and celebration being held on Monday, Dec. 4 on the Promega Corp. campus in Fitchburg, Wis.
In addition to conducting its annual business meeting, the association is sponsoring two special forums under the theme “The Cornerstones of Continued Growth: Securing Capital and Collaborations in 2007 and Beyond.” The forums will be led by leading venture capitalists and pharmaceutical company executives. A schedule of the afternoon’s events and a list of forum leaders is included below.
“Wisconsin’s bioscience industry has a lot to be proud of as we reflect on the accomplishments in 2006,” said James L. Leonhart, executive vice president of the association. “We look forward to continuing our leadership of the statewide dialogue about how to make the bioscience industry even stronger at our annual meeting, and during 2007 and beyond.”
Both association members and non-members are welcome to attend the afternoon’s events. There is a $35 registration fee for the event, which concludes with a gala reception featuring keyboard artist Leotha Stanley.
Those who would like more information about the event should call the association’s office at 608 252-9393.
More…
Event Details
WHAT: WBMA Annual Meeting and Celebration
WHEN: Monday, Dec. 4, 2006
WHERE: BioPharmaceutical Technology Center Institute (BTCI) 5445 East Cheryl Parkway Fitchburg, Wis.
Schedule
1:30-2 p.m. Registration
2-2:30 p.m. WBMA Annual Meeting
Special Forums The Cornerstones of Continued Growth: Securing Capital and Collaborations in 2007 and Beyond
2:30-3:45 p.m. Securing Capital: How Do Life Science Companies Qualify for Wisconsin’s Growing Funds? Forum Leaders: Jason Smith, Midwest director, Peak Ridge Capital Group Inc.; John Neis, senior partner, Venture Investors LLC, and; Dan Broderick, managing director, Mason Wells Inc.
3:45-4 p.m. Break
4-5:15 p.m. Collaborations: What Kinds of Partnerships and Alliances are the Major Pharmaceutical Companies Seeking with Life Science Companies? Forum Leaders: Gary Gabrielson, senior director, business development, Astellas Pharma Inc.; Mary Mayer Ph.D., associate director, strategic alliances, Pfizer Inc.; Terry Opegnorth Ph.D., divisional vice president, metabolic & infectious disease research and target & lead discovery, Abbott Laboratories
5:15-5:40 Keynote Address: The Future of Wisconsin’s Life Science Industry Randy Dimond, vice president & chief technical officer Promega Corp.
5:40-7 p.m. Gala Reception
